Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies-Reference-Cited by-同舟云学术

Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies

Published:2021-08-31 Issue: Volume: Page:1-11
ISSN:0731-5724
Container-title:Journal of the American College of Nutrition
language:en
Short-container-title:Journal of the American College of Nutrition

Author:

Ben-Eltriki Mohamed¹²,Hopefl Robert³,Wright James M.¹²⁴,Deb Subrata³

Affiliation:

1. Cochrane Hypertension Review Group, University of British Columbia, Vancouver, Canada

2. Therapeutics Initiative, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada

3. Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, Florida, USA

4. Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada

Publisher

Informa UK Limited

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/07315724.2021.1951891

Reference68 articles.

1. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. 2020. [cited 2020 October 14]; https://covid19.who.int/.

2. All about COVID-19 in brief

3. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses

4. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

5. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional and Inflammatory Markers Associated with SARS-CoV-2 Infection in the Elderly;International Journal of Molecular Sciences;2024-07-15

2. Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-05-27

3. The “Magnificent Seven” in Oral and Systemic Health against COVID-19;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-24

4. Clinical Outcomes among Hospitalized COVID-19 Patients Who Received Baricitinib or Tocilizumab in Addition to Standard of Care;Diseases;2024-05-20

5. Effect of Vitamin D3 Supplementation on Severe COVID-19: A Meta-Analysis of Randomized Clinical Trials;Nutrients;2024-05-07